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Introduction
Dysglycemia and glycemic variability (GV) are associated
with poor outcomes in critically ill patients. Target tempera-
ture management alters blood glucose (BG) homeostasis.
Objectives
To investigate the association between BG levels and GV and
the outcomes of patients randomized to target temperature
management at 33 or 36 °C after cardiac arrest (CA).
Methods
This is a post-hoc analysis of the TTM-trial [1], which
included 950 patients with out-of-hospital CA of pre-
sumed cardiac cause at 36 sites in Europe and Australia
from November 2010 to January 2013. A cerebral per-
formance category of 1 or 2 was considered a favorable
outcome. Patients who died during the first two days
were excluded. Blood samples were collected and ana-
lysed per protocol at seven time points (0, 4, 12, 20, 28,
32 and 36 h). In addition, we included all registered BG
values that were entered into the electronic case report
form at different times between the fixed time points, at
the discretion of the investigators. Four GV parameters
(median, range, SD and MAG) were used.
Results
874 patients, 437 in each of the temperature groups,
were included. Overall, 479 (55%) patients survived and
440 (50%) had a favorable neurological outcome.
Patients with a favorable outcome both had a lower
median BG level at admission (10.1 mmol/L vs 11.7
mmol/L, p < 0.001) and lower median BG levels during
the first 36 hours compared to patients with unfavorable
neurologic outcomes (fig 1). Hyperglycemia (>10 mmol/L)
was more common among patients with a poor outcome,
and hypoglycemia ( < 4 mmol/L) was associated with mor-
tality. The incidence of hypo- and hyperglycemia did not
differ between the two temperature groups. Overall, 52%
of the patients received insulin treatment, 230 (55%) in the
33 °C group vs 197 (48%) in the 36 °C group (p = 0.04).
Fewer patients with a good neurological recovery received
insulin treatment as compared to those with a poor neuro-
logical outcome (181 [43%] vs 250 [60%], p < 0.001).
In unadjusted analysis, all GV parameters were lower
among patients with a good outcome. In multivariate
analysis, range was a predictor of survival (p = 0.047,
OR 1.04 [1.00-1.09]) whereas median neither proved to
be an independent predictor of neurological outcome
(p = 0.15) nor of survival (p = 0.076). Range and SD
were higher in the 33 °C group, whereas median and
MAG did not differ between the temperature groups.
Conclusions
Patients with a favorable outcome had lower median BG
levels on admission, lower incidence of hyperglycemia
and required less insulin treatment while GV did not
differ between those with favorable and poor outcome.
There was no difference in dysglycemia incidence
between 33 °C and 36 °C, but more patients needed
insulin treatment and GV was higher with a target tem-
perature of 33 °C.
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